Open AccessSeroprevalence of anti-SARS-CoV-2 of IgG antibody by ELISA: Community-based, cross-sectional study from urban area of Malegaon, Maharashtra
Author(s) -
Pallavi Supriya Prabhakar Saple,
Shriram Gosavi,
Tushar Pawar,
Govind Chaudhari,
Hitesh Lotan Mahale,
Pradeep Deshmukh,
Ashish Kurundkar,
Sarang Pedgaonkar,
Sapana Thakare
Publication year - 2021
Publication title -
journal of family medicine and primary care
Language(s) - English
Resource type - Journals
eISSN - 2278-7135
pISSN - 2249-4863
DOI - 10.4103/jfmpc.jfmpc_2191_20
Subject(s) - seroprevalence , medicine , asymptomatic , subclinical infection , cross sectional study , serology , odds ratio , immunology , antibody , pathology
Given the high incidence of asymptomatic or subclinical SARS-CoV-2 infection, reported cases likely underestimate the overall prevalence and infectivity of COVID-19. Serological test for IgG can provide a better measure of disease activity by identifying asymptomatic or subclinical infection. This study was conducted to estimate the seroprevalence of SARS-CoV-2 infection and to the determinants of SARS-CoV-2 infection in the hotspot area of COVID-19.